ADC Therapeutics SA
Biotechnology
Healthcare
ADCT
105 M shares
NYSE US
traded
02 Apr 2025
listed
no
open
1.34
52 week high
4.01
high
1.37
52 week low
1.33
low
1.30
growth
-67.56 %
previous Close
1.35
P/E ratio
market cap
192 M
div yield
0
usd
Sep 2024
qoq
revenue
18.02 M
3.48 %
net incoming
-43.97 M
-20.32 %
eps
0.00 %
-10.53 %
eps surprise
-10.53 %
net profit margin
-244.06 %
-34.00 %
operating incoming
-35.56 M
-22.46 %
net change in cash
-25.85 M
-139.26 %
cash on hand
274 M
-8.61 %
cost of revenue
851 K
-58.59 %
top top